Telethon Kids Institute has received $2.66 million from BHP to lead a trial testing the effectiveness of multiple sclerosis drug interferon in reducing the infectiousness of COVID-19 patients.
06/05/2020 - 13:44
Telethon Kids Institute to lead COVID-19 drug trial
06/05/2020 - 13:44
